DNA-Based Nanostructures and Their Biomedical Applications
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 86
Special Issue Editors
Interests: biomolecular engineering; protein-DNA hybrid structures; cancer therapy; disease diagnosis and treatment; virus inhibition; drug delivery; high-resolution bioimaging
Special Issue Information
Dear Colleagues,
DNA-based nanostructures have emerged as a promising frontier in biomedical research, leveraging the unique properties of DNA molecules for diverse applications. These nanostructures are intricately designed using the principles of DNA self-assembly, exploiting the specificity of base pairing to create precise and programmable architectures at the nanoscale.
In the realm of biomedical applications, DNA-based nanostructures exhibit tremendous potential. They can serve as targeted drug delivery vehicles, allowing for the controlled release of therapeutic agents at specific sites within the body. Additionally, these nanostructures are employed in imaging technologies, enabling the detection and visualization of biological molecules with high precision. Diagnostic tools, such as biosensors, benefit from the programmability of DNA nanostructures, offering a platform for the sensitive and selective detection of biomarkers associated with diseases.
Furthermore, DNA-based nanodevices find utility in the field of regenerative medicine, contributing to the controlled assembly of tissue-engineering scaffolds. The ability to engineer these nanostructures with functional components enhances their versatility in biomedical applications, ranging from cancer treatment to gene therapy. As research progresses, the integration of DNA-based nanostructures into clinical practice holds the promise of revolutionizing diagnostics, therapeutics, and regenerative medicine, ushering in a new era of precision medicine.
This Special Issue aims to highlight the recent advances and breakthroughs in the field of DNA nanotechnology, shedding light on the latest developments, challenges, and future prospects. Original research articles and comprehensive reviews are welcome for submission.
Dr. Xing Wang
Dr. Mengxi Zheng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- DNA origami
- DNA nanotechnology
- DNA self-assembly
- nanomedicine
- theranostics
- drug delivery
